Danish Central Bank Doubles Growth Forecast on Novo’s US Boom
Denmark’s central bank more than doubled its growth forecast for this year as surging US sales and production at Novo Nordisk A/S fuel strong exports in the Nordic country’s pharmaceutical industry.
← Back to stories
National2 articles from 2 sources across the spectrum· Updated 6d ago
2 across the spectrum · tap a section to jump
How each side is putting it
Left
1 viewpointCenter
0 viewpointsNo Center coverage yet.
A blind spot on this side of the story.
Right
1 viewpointU.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast